A curated list of the best psychedelic documentaries — with accuracy notes on where each film's claims align with or get ahead of the clinical evidence.
Documentary films have done more to move public understanding of psychedelic therapy than almost any academic paper. They put faces to clinical data and bring research out of journals into living rooms. But they also compress, select, and advocate. Before you make any decisions about treatment, you need to know what a film gets right, what it glosses over, and where the evidence has moved since filming. This guide does that work for you.
The films below represent the strongest available documentary content on psychedelic therapy, research, and culture. Each entry includes streaming availability as of mid-2026, a brief description, and an accuracy note from The Psychedelic Journal's editorial team.
A four-part docuseries based on Michael Pollan's bestselling book of the same name. Each episode covers one substance: LSD, psilocybin, MDMA, and mescaline. Pollan interviews researchers, therapists, and patients. He also participates in guided sessions himself. The series is well-produced and widely viewed.
Accuracy note: The clinical evidence sections are presented accurately and reflect the published trial data at the time of filming. The personal-use segments may give the impression that access is easier or more widespread than it actually is. Pollan's experiences took place in unregulated settings. Legal, supervised access remains narrow. For a current picture of legal access, see our psilocybin guide.
A visually striking documentary about psilocybin mushrooms and the broader world of mycology. Mycologist Paul Stamets is the central figure. The film covers the history of psilocybin research, its potential therapeutic uses, and the ecological role of fungi. It is one of the most-watched psychedelic documentaries available.
Accuracy note: Some therapeutic claims in the film were ahead of the published evidence at the time of filming in 2019. The Phase 2 and Phase 3 trial data that followed has since advanced significantly and, in many cases, supports the direction of the film's claims. However, the film presents certain outcomes as more established than the trial record at that time supported. Watch with that context in mind. Our psilocybin guide reflects the current evidence base.
This documentary covers five controlled substances: LSD, psilocybin, MDMA, cannabis, and ayahuasca. It features interviews with researchers and advocates and takes a broadly pro-reform position. At the time of release it was one of the most comprehensive documentary overviews of psychedelic science available.
Accuracy note: The film is now more than a decade old. Several sections rely on early Phase 1 and Phase 2 data that has since been superseded by larger trials. Some treatment claims made in the film are now better supported; others have not been replicated. Treat this as historical context rather than current clinical guidance. For updated information, see our sources page.
A personal documentary following a young American man who travels to the Amazon to undergo ayahuasca ceremonies after conventional medicine fails to treat his severe depression. The film focuses on his relationship with a Shipibo healer and the retreat experience itself.
Accuracy note: The film depicts retreats accurately as intense, non-medical experiences that carry real psychological risk. It does not overstate therapeutic claims or present the outcome as a guaranteed cure. The film also does not engage with the clinical trial literature on ayahuasca. For that, see our ayahuasca guide. People considering a retreat should read about preparation, contraindications, and integration before traveling.
A shorter-form documentary and investor-facing content series produced around MindMed, a publicly traded psychedelic medicine company. It covers the science of psychedelic-assisted therapy from a corporate and clinical research perspective. Useful for understanding how psychedelic drug development works as an industry.
Accuracy note: This content was produced with investor audiences in mind. The framing is promotional. Clinical claims should be verified against published trial data. Treat it as a starting point for understanding the commercialization landscape, not as an independent clinical summary.
A documentary filmed inside an actual Phase 2 clinical trial of MDMA-assisted therapy for PTSD, conducted in Israel. The film follows two participants through the full treatment arc: preparation sessions, the MDMA session itself, and integration. It is the most clinically grounded documentary on this list.
Accuracy note: This is a highly accurate clinical depiction. The trial footage reflects how MDMA-assisted therapy is actually conducted under a supervised protocol. The results shown are consistent with what the broader MAPS Phase 2 and Phase 3 trial data reported. This film is the closest thing to a primary source available in documentary form. See our MDMA guide for the full clinical context.
A documentary following a woman's personal use of ibogaine and psilocybin to treat opioid addiction. The film is candid and closely observed. It documents what the experience is actually like in a non-clinical, underground setting.
Accuracy note: The personal case is well-documented and the film avoids oversimplifying the outcome. However, ibogaine's cardiac risks — including potentially fatal QT-interval prolongation — are not prominently foregrounded. Anyone researching ibogaine should understand these risks before pursuing treatment. Our ibogaine guide covers the safety profile in detail. The film should not be used as a how-to guide.
Every documentary on this list was made by people who believe in the potential of psychedelic therapy. That is not a disqualification — but it is important context. Here is how to watch critically.
Documentaries are advocacy, not peer review. Film is a persuasion medium. Filmmakers choose which researchers to interview, which patient stories to include, and how to frame outcomes. That does not make the films wrong. It means you should read the underlying research to form your own view.
Trial data has changed since many filming dates. Several films on this list were made in 2013, 2016, and 2019 — before the major Phase 2 and Phase 3 trials reported results. The science has moved in both directions. Some early claims have been confirmed. Others have not held up. A film's age is relevant to how much weight you give its clinical claims.
No documentary is a substitute for a clinical consultation. A film cannot assess your medical history, current medications, or contraindications. If you are considering any psychedelic-assisted therapy, talk to a licensed clinician who knows your situation. Use documentaries to inform questions, not to make treatment decisions.
Watch for conflicts of interest. Some films are associated with companies, advocacy organizations, or individuals with financial stakes in psychedelic medicine. That is not automatically disqualifying — many researchers are also advocates — but it is worth knowing who funded or produced the film you are watching.
Films are a starting point. Primary research and clinical guidance give you the full picture. These internal resources from The Psychedelic Journal cover the substances and topics these documentaries raise.
How to Change Your Mind (2022) is the most comprehensive and widely available. The four-part series adapts Michael Pollan's book and covers psilocybin, LSD, MDMA, and mescaline with input from clinical researchers. It is broadly accurate on the clinical evidence, though the personal-use segments may understate how difficult legal access actually is for most people.
Mostly yes, with caveats. Fantastic Fungi (2019) covers psilocybin mushrooms and the role of mycelium in ecosystems accurately. Some therapeutic claims in the film were ahead of the evidence at the time of filming; the field has advanced significantly since, with two positive Phase 3 trial results for psilocybin in 2025. The ecological content about mycorrhizal networks holds up well.
Yes. Trip of Compassion (2020) is one of the most clinically accurate psychedelic documentaries available. It follows PTSD patients through an actual Israeli Phase 2 MDMA-assisted therapy trial, showing the preparation, session, and integration stages. It does not overstate the evidence and depicts the medical supervision required. Note that MDMA therapy is still not FDA-approved as of 2026.
How to Change Your Mind is on Netflix. Fantastic Fungi is available on Amazon Prime and Peacock. The Last Shaman is on Netflix. Neurons to Nirvana is on Vimeo and some digital platforms. Trip of Compassion is available via Yes Studios and select streaming platforms. Dosed is available on various digital platforms. Streaming availability changes frequently — check your platform for current status.
Get psychedelic research & policy updates
New trials, FDA decisions, and legal changes for psychedelic — delivered when they happen.
Suggest a tool, topic, or improvement that would make this site more useful.